No Data
No Data
12 Health Care Stocks Moving In Friday's After-Market Session
Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
Express News | Polyrizon Reports Successful Safety Study of a Formulation of Pl-14 Allergy Blocker in Human Nasal Tissue Model
Polyrizon Ltd. Shareholders Approve Key Amendments at Annual Meeting
Express News | Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements
Express News | Polyrizon Ltd - Enters Agreement With Global Branding Consultancy Firm